Company profile
Ticker
CLB
Exchange
Website
CEO
Mr. Lawrence V. Bruno
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Core Laboratories Australia PTY LTD • Core Laboratories Canada Ltd. • Core Laboratories International B.V. • Core Laboratories LP • Core Laboratories Malaysia SDN BHD • Core Laboratories Sales B.V. • Core Laboratories (U.K.) Limited • Owen Oil Tools LP • Saybolt Nederland B.V. • Saybolt LP ...
CLB stock data
Latest filings (excl ownership)
15F-12G
Securities registration termination (foreign)
12 May 23
25-NSE
Exchange delisting
2 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 May 23
Transcripts
CLB
Earnings call transcript
2023 Q4
1 Feb 24
CLB
Earnings call transcript
2023 Q2
27 Jul 23
CLB
Earnings call transcript
2023 Q1
27 Apr 23
CLB
Earnings call transcript
2022 Q4
2 Feb 23
CLB
Earnings call transcript
2022 Q3
27 Oct 22
CLB
Earnings call transcript
2022 Q2
28 Jul 22
CLB
Earnings call transcript
2022 Q1
28 Apr 22
CLB
Earnings call transcript
2021 Q4
3 Feb 22
CLB
Earnings call transcript
2021 Q3
28 Oct 21
CLB
Earnings call transcript
2021 Q2
29 Jul 21
Latest ownership filings
SC 13G/A
ALGER ASSOCIATES INC
12 Jun 23
4
Dijken Eeuwijk Monique van
3 Apr 23
4
Kwaku Temeng
3 Apr 23
4
Michael Straughen
3 Apr 23
4
Katherine Murray
3 Apr 23
4
Harvey Robert Klingensmith
3 Apr 23
4
Martha Z. Carnes
3 Apr 23
4
Mark Damian Tattoli
21 Feb 23
4
Christopher Scott Hill
21 Feb 23
4
Gwendolyn Gresham
21 Feb 23
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q | |
Cash on hand (at last report) | 16.29 mm | 16.29 mm | 16.29 mm | 16.29 mm | 16.29 mm | 16.29 mm |
Cash burn (monthly) | (no burn) | 479.33 k | (no burn) | (no burn) | 1.06 mm | (no burn) |
Cash used (since last report) | n/a | 10.87 mm | n/a | n/a | 23.95 mm | n/a |
Cash remaining | n/a | 5.42 mm | n/a | n/a | -7.66 mm | n/a |
Runway (months of cash) | n/a | 11.3 | n/a | n/a | -7.3 | n/a |
Institutional ownership, Q2 2024
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
News
Core Laboratories Q4 2024 Adj EPS $0.22, Inline, Sales $129.24M Miss $132.44M Estimate
2w ago
Insights into Core Laboratories Q4 Earnings
2w ago
Earnings Scheduled For January 29, 2025
3w ago
Arm Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
1mo ago
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket
1mo ago